Evaluation of Group A Beta Hemolytic Streptococci Macrolide Resistance in Turkey: Pilot Study Results

Basit Öğe Kaydı
dc.authoridEmiroglu, Melike/0000-0003-1307-0246
dc.contributor.authorKara, Ates
dc.contributor.authorParlakay, Aslinur Ozkaya
dc.contributor.authorGur, Deniz
dc.contributor.authorCengiz, Ali Bulent
dc.contributor.authorTezer, Hasan
dc.contributor.authorCiftci, Ergin
dc.contributor.authorKeser, Melike
dc.date.accessioned2024-09-18T20:26:31Z
dc.date.available2024-09-18T20:26:31Z
dc.date.issued2011
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractObjective: In this study, it is aimed to attain a general opinion about macrolide resistance and its prevalance in group A beta hemolytic Streptococci all over the country by studying isolates of group A beta hemolytic Streptoccocci causing tonsillopharyngitis from 8 centers in Turkey. In this study, the first results of macrolide resistance in a continuing study are reported. Material and Methods: From the first centers, isolates of group A beta hemolytic Streptococci from patients 5- 15 years of age, throat cultures were carried via transport medium ( blood agar- bacitracin) to Hacettepe University Medical Faculty Hospital and with disc diffusion technique erythromycin, clarithromycin, azithromycine and clindamycin resistance was studied. Results: From Hacettepe University Hospital 75 isolates, from Ankara University Hospital18 isolates, from Ankara Hematology andOncology Hospital 31 isolates, from Seleuk University Hospital 51 isolates, from Suleyman Demirel University Hospital 69 isolates, from Mustafa Kemal University Hospital 14 isolates, from Bakirkoy Sadi Konuk Research Hospital 9 isolates and from Ankara Akay Hospital 20 isolates were obtained which yielded 287 group A beta hemolytic Streptococci. Intermediate erythromycin resistance of the strains was 2%, intermediate clindamycin resistance of the strains was 1.1%, intermediate azithromycin resistance of the strains was 1.8% and intermediate clarihtromycin resistance of the strains was 1.8%. Erythromycin resistance of group A beta hemolytic Streptococci was 1.3%, azithromycin resistance of group a beta hemolytic Streptococci was 2.8%, clarithromycin resistance of group A beta hemolytic Streptococci was 1.3%. Conclusion: In this study the anxiety that macrolide resistance of group A beta hemolytic Streptococci in our country is high should not be a serious problem. However macrolide resistance should be followed up intermittently with national and regional studies. Our study is continuing with the isolates from 20 centers and this study is presented to demonstrate pilot findings.en_US
dc.identifier.doi10.5152/ced.2011.35
dc.identifier.endpage99en_US
dc.identifier.issn1307-1068
dc.identifier.issn1308-5271
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-80053440191en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage96en_US
dc.identifier.urihttps://doi.org/10.5152/ced.2011.35
dc.identifier.urihttps://hdl.handle.net/20.500.12483/10370
dc.identifier.volume5en_US
dc.identifier.wosWOS:000422202700002en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherAves Yayincilik, Ibrahim Karaen_US
dc.relation.ispartofJournal of Pediatric Infectionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGrup A beta hemolytic streptococcusen_US
dc.subjectmacrolideen_US
dc.subjectchilden_US
dc.titleEvaluation of Group A Beta Hemolytic Streptococci Macrolide Resistance in Turkey: Pilot Study Resultsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full Text
Boyut:
60.61 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu